Home LiteratureArticle Details
PMID: 1557361 Published · ppublish English Journal Article

Postsynaptic protein kinase C essential to induction and maintenance of long-term potentiation in the hippocampal CA1 region.

Wang JH, Feng DP

Abstract

Previous studies on the effects of protein kinase C (PKC) inhibitors intracellularly introduced into the postsynaptic neuron on long-term potentiation (LTP) in the hippocampal CA1 region showed that given before the tetanic stimulation they only blocked the development of the maintenance phase of LTP and that given after the tetanus they did not affect the continued maintenance of established LTP. We now report different results in such experiments obtained by looking into the dose-effect relationship of the inhibitors given to the postsynaptic neuron and making use of a synergistic effect of two inhibitors given together. We used the following three PKC inhibitors: polymyxin B (PMB), PKC-(19-31), and H7. With the intracellular delivery of the inhibitor(s) beginning 30 min before the tetanus, PMB in adequate dosage or a combination of PMB and PKC-(19-31), each at a low dosage, could block the development of LTP completely including its initial induction phase. With the delivery beginning at the time of the tetanus, PKC-(19-31) or H7 slowly caused the established LTP to decline to the baseline; this decline was greatly accelerated when PMB and PKC-(19-31) or PMB and H7 were given together. PMB and PKC-(19-31) given together 75-90 min or even 3 h after the tetanus caused a decline of the maintained LTP similar to the decline observed when both inhibitors were given at the time of the tetanus. These results show that postsynaptic PKC is essentially involved in both the initial induction and the subsequent maintenance of LTP, contrary to current views on the subject.

MeSH Terms
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine Animals Enzyme Activation/drug effects Hippocampus/physiology In Vitro Techniques Isoquinolines/pharmacology Neuronal Plasticity Piperazines/pharmacology Polymyxin B/pharmacology Protein Kinase C/antagonists & inhibitors,metabolism Rats Rats, Inbred Strains Synapses/enzymology
Chemicals
Isoquinolines Piperazines 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine Protein Kinase C Polymyxin B
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wang J H
Shanghai Institute of Physiology, Chinese Academy of Sciences.
Feng D P
References (20)
20 references, click to expand
  1. Polymyxin B, an inhibitor of protein kinase C, prevents the maintenance of synaptic long-term potentiation in hippocampal CA1 neurons.
    Brain Res. 1988 Feb 9;440(2):305-14 PMID: 2833996
  2. Activation of a K-252b-Sensitive Protein Kinase is Necessary for a Post-Synaptic Phase of Long-Term Potentiation in Area CA1 of Rat Hippocampus.
    Eur J Neurosci. 1990;2(6):481-6 PMID: 12106018
  3. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.
    Biochemistry. 1984 Oct 9;23(21):5036-41 PMID: 6238627
  4. Postsynaptic factors control the duration of synaptic enhancement in area CA1 of the hippocampus.
    Neuron. 1991 Jan;6(1):53-60 PMID: 1670922
  5. Mechanisms underlying long-term potentiation of synaptic transmission.
    Annu Rev Neurosci. 1991;14:379-97 PMID: 1851607
  6. Protein kinase C activity is not responsible for the expression of long-term potentiation in hippocampus.
    Proc Natl Acad Sci U S A. 1990 Jun;87(11):4073-7 PMID: 2161529
  7. Presynaptic enhancement shown by whole-cell recordings of long-term potentiation in hippocampal slices.
    Nature. 1990 Jul 12;346(6280):177-80 PMID: 2164158
  8. Presynaptic mechanism for long-term potentiation in the hippocampus.
    Nature. 1990 Aug 23;346(6286):724-9 PMID: 2167454
  9. Glutamate activates multiple single channel conductances in hippocampal neurons.
    Nature. 1987 Feb 5-11;325(6104):522-5 PMID: 2433593
  10. The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture.
    J Physiol. 1988 May;399:247-66 PMID: 2457089
  11. Physiological mechanisms underlying long-term potentiation.
    Trends Neurosci. 1988 Apr;11(4):156-62 PMID: 2469184
  12. Strengthening the synapses.
    Nature. 1989 Apr 6;338(6215):460-1 PMID: 2538758
  13. An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation.
    Nature. 1989 Aug 17;340(6234):554-7 PMID: 2549423
  14. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP.
    Science. 1989 Aug 25;245(4920):862-6 PMID: 2549638
  15. Temporally distinct pre- and post-synaptic mechanisms maintain long-term potentiation.
    Nature. 1989 Apr 6;338(6215):500-3 PMID: 2564640
  16. Protein kinase C and long-term potentiation in the hippocampus.
    Trends Pharmacol Sci. 1989 Jun;10(6):236-9 PMID: 2672464
  17. Persistent protein kinase activity underlying long-term potentiation.
    Nature. 1988 Oct 27;335(6193):820-4 PMID: 2847049
  18. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain.
    Science. 1987 Dec 18;238(4834):1726-8 PMID: 3686012
  19. Polymyxin B is a more selective inhibitor for phospholipid-sensitive Ca2+-dependent protein kinase than for calmodulin-sensitive Ca2+-dependent protein kinase.
    Biochem Biophys Res Commun. 1982 Dec 31;109(4):1129-33 PMID: 6301427
  20. A persistent postsynaptic modification mediates long-term potentiation in the hippocampus.
    Neuron. 1988 Dec;1(10):911-7 PMID: 2908443
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1992-04-01
Pages
2576-80
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC48704
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]